MEA Transplant Diagnostics Market

MEA Transplant Diagnostics Market Size (2023 to 2028)

The Middle East and Africa transplant diagnostics market size is estimated to grow from USD 200.8 million in 2023 to USD 264.8 million by 2028, growing at a CAGR of 5.69% from 2023 to 2028.

The growing number of organ transplantation procedures across the Middle East and Africa is one of the major factors driving the transplant diagnostics market in this region. Due to the growing patient population suffering from chronic diseases, organ transplantation procedures are increasing in the Middle East and African countries. In addition, the rising number of kidney failure cases among the Middle East and African population, increasing healthcare expenditure and the rising adoption of technological developments in transplant diagnostics among MEA countries are expected to favor regional market growth. The growing efforts by market participants in developing advanced transplant diagnostics and innovative technologies for organ transplantation are further fuelling the market's growth rate.

The growing aging population across MEA, an increasing number of initiatives from the governments of MEA countries to promote organ donation and transplantations have increased the number of transplant procedures and favorable reimbursement policies for transplant procedures and diagnostics contribute to the growth of the MEA market. The growing awareness regarding organ donation and transplant procedures among the public, the growing medical tourism, the shortage of organs, increasing disposable income and the rising prevalence of infectious diseases such as HIV and hepatitis further boost the growth rate of the MEA transplant diagnostics market.

However, the lack of healthcare infrastructure and skilled professionals and the high costs associated with diagnostics are hampering the growth rate of the transplant diagnostics market in the Middle East and African region. In addition, the lack of awareness around transplant diagnostics in some MEA countries further inhibits market growth.

This research report on the Middle East & Africa transplant diagnostics market has been segmented & sub-segmented into the following categories.

By Technology:

• Molecular Assays
  • PCR-Based Molecular Assays
    • Real-Time PCR
    • Sequence-Specific Primer-PCR
    • Sequence-Specific Oligonucleotide-PCR
    • Other PCR-Based Molecular Assays
  • Sequencing-Based Molecular Assays
    • Sanger Sequencing
    • Next-Generation Sequencing
    • Other Sequencing Molecular Assays
• Non-Molecular Assays

By Product:

• Consumables
• Instrument
• Reagent
• Software & Services

By Application:

• Diagnostic Applications
  • Pre-Transplantation Diagnostics
    • Infectious Disease Testing
    • Histocompatibility Testing
    • Blood Profiling
  • Post-Transplantation Diagnostics
• Research Applications

By Transplant Type:

• Heart Transplant
• Kidney Transplant
• Liver Transplant
• Stem Cell Transplant

By End-User:

• Labs
• Hospitals
• Transplant Centres
• Research Labs & Academic Institutes

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa region accounted for a moderate share of the global market share in 2022. However, the market is expected to showcase a slightly better occupancy in the global market during the forecast period owing to the increasing prevalence of chronic kidney disease (CKD), liver disease, and chronic lung and heart diseases, which result in increased mortality. This is expected to increase the number of organ transplantation procedures in this region, which drives the transplant diagnostics market forward. Furthermore, in recent years transplantation has improved due to better surgical techniques, increasing using advanced technology innovations in organ donation, and mainly transplant diagnostics. As a result, Africa holds the maximum share of the market growth in this region. In addition, South Africa is conducting an advanced transplant program to increase organ donation and organ transplant procedures.

Due to the increasing incidence of heart disease in Saudi Arabia, the MEA market is expected to see favorable growth. As a result, the people in this region opt for heart transplantation to increase their lifespan. Increasing awareness about the transplant diagnostics procedure in this region drives the market ahead. Saudi Arabia's government made several programs to increase awareness about transplant diagnostics and uses for a patient who wants to go through organ transplantation by spending a large amount of money.

Due to an increasing number of organ transplant centers and organ donors in the UAE, the market has had favorable growth in this region. In addition, the government has increased approval of organ transplants procedure under specific rules and regulations for the safety and legality of a patient.

KEY MARKET PLAYERS:

Companies such as CareDx, Pacific Biosciences of California, Illumina, Thermo Fischer Scientific, GenDx, and Immucor are expected to account for a significant share of the MEA transplant diagnostics market.